Grant directory

Between cycles

Lets early-stage deep tech founders worldwide pitch investors live for partner prizes in Riga.

Between cycles

Subsidises Japanese deep-tech startups running joint R&D projects with a partner-country business.

Between cycles

Gives Liverpool health start-ups up to £50,000 zero-equity cash plus £10,000 R&D vouchers.

Between cycles

Supports physicians entering inherited retinal degeneration subspecialty training to build clinician-scientists for vision-preserving therapies.

Between cycles

Funds Duke faculty, staff, students and trainees $25,000 to $60,000 a year to pilot practical healthcare innovation projects inside Duke's clinical enterprise.

Between cycles

Supports United Kingdom cancer science programmes with multi-stage funding for innovation in disease biology.

Between cycles

Funds disease-model development programs for IRD and AMD translational research.

Between cycles

Funds non-drug research that removes a barrier to diagnosing, monitoring or accurately predicting the course of Alzheimer's disease and related dementias.

Between cycles

Funds developing or validating the biomarkers and outcome measures that make ALS clinical trials sharper, not the trials themselves.

Between cycles

Funds a phase 1 or small phase 2 ALS clinical trial that must start within a year of the award, with a biomarker built in for any drug, biologic or device.

Between cycles

Funds a clinical trial of a new autism treatment, product or device, from a small proof-of-concept study up to a full efficacy trial.

Between cycles

Funds preclinical or clinical Duchenne muscular dystrophy research, at a smaller or a larger funding level.

Between cycles

Funds turning preclinical burn-care findings into an actual product — a device, a drug, or a clinical practice guideline.

Between cycles

Funds clinical trials of ovarian cancer drugs, biologics, devices or guidance, from small pilots to large efficacy studies.

Between cycles

Funds cancer clinical trials from first-in-human through phase III, with regulatory filings already due at the application deadline.

Between cycles

Funds a multi-investigator platform product through translational and early-phase trials, with each partnering investigator on a separate award.

Between cycles

Funds either a drug-discovery study or a clinical diagnostic approach for Lyme disease and other tick-borne diseases, aimed at something a clinic could use.

Between cycles

Funds a clinical trial for psychological health conditions or traumatic brain injury, at a pilot or a larger effectiveness scale the applicant chooses.

Between cycles

Funds Duke BME and clinical faculty teams translating bioengineering research toward patient benefit and commercial products.

Between cycles

Supports cancer detection and diagnosis innovation in the United Kingdom through transformational early development programmes.

Between cycles

Funds research into what is driving more non-hereditary cancers in 18-to-49-year-olds, and how to catch them earlier.

Between cycles

Supports Delaware firms with innovation credits for experimentation and technology development.

Between cycles

Pays up to 75% of an MSME's product-design project cost, capped at Rs. 40 lakh.

Between cycles

Funds Romanian diaspora entrepreneurs starting businesses back home with up to 200,000 euros.